Recombinant Anti-G250 × Anti-CD55 Bispecific Antibody (CrossMab) (CAT#: CROSS-L018)
Recombinant Anti-G250 × Anti-CD55 Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgG shaped entity that binds each ligand with one arm. This BsAb can active complement. It was designed for the treatment of cervical carcinoma.
Specific Inquiry
Specifications
- Target
- G250 & CD55
- Type
- CrossMab
- Species Reactivity
- Human
- Target 1
- G250
- Host Species 1
- Mouse
- Target 2
- CD55
- Host Species 2
- Mouse
- Application
- FuncS, Promising therapeutic agent
- Related Disease
- Cervical carcinoma
Target
- Target 1
- G250
- Alternative Names
- G250; renal cell carcinoma; renal cell carcinoma
- Target 2
- CD55
- Gene ID
- 1604
- UniProt ID
- P08174
- Alternative Names
- CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for CROSS-L018. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.